Acrivon Therapeutics, Inc. Common Stock (ACRV) stock forecast · $65.1M cap
Acrivon Therapeutics, Inc. Common Stock (ACRV) is a biotechnology company listed on NASDAQ.
This ACRV forecast page states what the cached financials imply — not a price target and not a guarantee. Acrivon Therapeutics, Inc. Common Stock outlooks on Lician start from reported revenue and the latest filing, then you decide.
No cached income statement for ACRV yet, so there is no numeric 2026 base to extend.
Period-over-period revenue change is not in cache for ACRV, so this page does not invent a growth rate.
ACRV currently screens at market cap $65.1M. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next ACRV 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the ACRV stock page.
Not investment advice.